Results 101 to 110 of about 5,721 (196)
Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathy
Background: Impaired coronary flow reserve (CFR) is a significant predictor of poor prognosis in patients with idiopathic dilated cardiomyopathy (IDC).
Dogan Erdogan +6 more
doaj
We aimed to investigate the pharmacoeconomic efficacy of ivabradine and nebivolol in treatment of stable angina pectoris patients with left ventricular dysfunction prospectively. Pharmacoeconomic analysis was performed by using cost minimization analysis,
Rasim Kutlu +2 more
doaj
Aim. To optimize chronic heart failure (CHF) pharmacotherapy, basing on endothelin (ET) system activity, functional and cardio-hemodynamic parameters, and their dynamics in beta-adrenoblocker nebivolol therapy. Material and methods. The study included 52
L. I. Olbinskaya, Yu. I. Naymann
doaj
Valsartan, Nebivolol and Blood Pressure
BackgroundThe exploration of Blood Pressure (BP) variability and of the influence of different antihypertensive drugs on BP variability may improve understanding of the mechanism involved in BP changes induced by drugs.
Stefania Negrea; “luliu Hatieganu” University of Medicine and Pharmacy Cluj-Napoca, Romania +2 more
core
Model-informed dose optimization of carvedilol and nebivolol in cirrhotic patients: a pilot randomized clinical study. [PDF]
Tarek M +4 more
europepmc +1 more source
Early Detection of Nebivolol-Induced Hepatotoxicity. [PDF]
Torunova AM, Kireeva VV, Kurganskii IS.
europepmc +1 more source
Nebivolol Inhibits Hepatocellular Carcinoma via RHOQ and Enhances the Efficacy of Lenvatinib. [PDF]
Zhang S +15 more
europepmc +1 more source
Comparative Effectiveness and Outcomes of Nebivolol Versus Other Beta Blockers in Patients With Hypertension: A Multicenter Cohort Study. [PDF]
Chang YC +4 more
europepmc +1 more source

